House Bill 2376
115th Congress(2017-2018)
Drug Diversion and Counterfeit Crackdown Act of 2017
Introduced
Introduced in House on May 4, 2017
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2376
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Drug Diversion and Counterfeit Crackdown Act of 2017
This bill makes it illegal except in cases of a drug shortage to import into the United States prescription drugs manufactured outside the United States and intended by the manufacturer or labeled to be marketed outside the United States.
The bill establishes a penalty for knowingly dispensing or selling a counterfeit drug.
May 4, 2017
05/05/2017
Referred to the Subcommittee on Health.
05/04/2017
Referred to the House Committee on Energy and Commerce.
05/04/2017
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:36:48 PM